• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Metals
    Tech
    Life Science
    Longevity Market
    Longevity News
    Longevity Stocks
    • Longevity Market
    • Longevity News
    • Longevity Stocks

    Avagenesis Corp Announces Canadian Notice of Patent Allowance

    Morag Mcgreevey
    Sep. 30, 2015 09:16AM PST
    Longevity Investing

    Avagenesis Corp. (TSXV: VVA) has announced that it has received a Notice of Allowance from the Canadian Intellectual Property Office.

    Avagenesis Corp. (TSXV: VVA) has announced that it has received a Notice of Allowance from the Canadian Intellectual Property Office.
    According to the press release:
    [The notice] is for a patent application on adipose cell isolation technology.  The Company anticipates the patent to be issued within 60 days.  
     
    Once that occurs, patents will have been issued on the Company’s licensed technology in a total of eight jurisdictions (the others being the United States, Australia, Singapore, Russia, Japan, South Korea and China). Avagenesis expects more patent issuances internationally over the next 18 months. 
    Click here to read the full press release from Avagenesis.

     

    russiachinaaustraliaunited states
    The Conversation (0)

    Go Deeper

    AI Powered
    Senior woman doing exercises alongside closeup of DNA.

    5 US Longevity and Anti-aging Stocks to Watch in 2025

    Enveric Biosciences Further Enhances Intellectual Property Estate with New U.S. Patent Issuance

    Enveric Biosciences Further Enhances Intellectual Property Estate with New U.S. Patent Issuance

    Latest News

    Outlook Reports world

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Stocks

    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES